Clinilabs

CNS Clinical Trial Expertise

Clinilabs is the industry's leading CNS CRO, specializing in the development of neurotherapeutics—drugs, devices, and technologies. With 25+ years of experience, the company brings therapeutic area and indication-level mastery to every study, supporting development across 25+ CNS indications including psychiatry, neurology, substance use disorders, and rare CNS disorders.

Service Offerings

• Phase 2–4 Trial Management: Full-service outsourcing for mid- and late-stage clinical development
• Early Phase Development: Phase 1 and Phase 0 capabilities
• Clinical Research Units: In-house facilities for early-phase studies
• Clinical Trial Services & Technology: Operational and technology infrastructure
• Corelab Services: Central laboratory support
• Advisory & Regulatory: Regulatory strategy and submissions support
• MedTech Expertise: Diagnostic and therapeutic device development, with 35+ MedTech trials conducted in less than 10 years and experience across 9+ device and technology categories

Global Reach

Clinilabs maintains a global footprint with headquarters in New Jersey and regional offices in New York, Switzerland (European headquarters), Paris, China, and Tokyo. The company has earned 800+ clinical trial awards and supported 30+ marketed products.

Regulatory Recognition

Quality and operational proficiency are recognized by sponsors and regulatory authorities worldwide, including North America and Europe.